PKIS v2.0 A clinical tool for identifying important pharmacokinetic drug-drug interactions
| 1. Accepted major perpetrators | 2. Rejected perpetrators | 3. Unclassifiable | 4. Full table |

sulfaphenazole

  • sulfaphenazole is not available in Australia/New Zealand, despite evidence suggesting that it may perturb the activities of CYP2C9.
  • CYP2C9
    Not available in Australia or New Zealandazapropazone
    benzbromarone
    bucolome
    indisulam
    lornoxicam
    miconazole [a]
    nizatidine
    oxandrolone
    phenylbutazone
    secobarbital
    stiripentol
    sulfamethizole
    sulfaphenazole
    sulfinpyrazone

    Footnotes and References

    a.systemic preparations not available in Australia or New Zealand.
    Disclaimer
    WARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy. Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.